Cas:90176-80-0 4-Fluoro-2-(trifluoromethyl)benzaldehyde manufacturer & supplier

We serve Chemical Name:4-Fluoro-2-(trifluoromethyl)benzaldehyde CAS:90176-80-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Fluoro-2-(trifluoromethyl)benzaldehyde

Chemical Name:4-Fluoro-2-(trifluoromethyl)benzaldehyde
CAS.NO:90176-80-0
Synonyms:5932091;4-fluoro-2-trifluoromethyl benzaldehyde;5-Fluoro-2-formylbenzotrifluoride;4-Fluoro-2-(trifluoromethyl)benzaldehyde;Benzaldehyde, 4-fluoro-2-(trifluoromethyl)-;α,α,α,4-Tetrafluoro-o-tolualdehyde;VHR DF BXFFF;MFCD00061313
Molecular Formula:C8H4F4O
Molecular Weight:192.110
HS Code:2913000090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:195.0±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.459
PSA:17.07000
Exact Mass:192.019821
LogP:2.32

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1989 3/PG 3
Packing Group:III


Contact us for information like 5932091 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00061313 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00061313 Use and application,α,α,α,4-Tetrafluoro-o-tolualdehyde technical grade,usp/ep/jp grade.


Related News: Jan Vertommen, Senior Director, Commercial Development, Lonza, said, “Increasing our capabilities by adding mid-scale API manufacturing at our site in Nansha will benefit our customers, and especially the many global emerging biotech companies we partner with. 2,7,11-Trimethyl-dodec-10-en-5-ol manufacturers During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. 2-Bromo-5-tert-butyl-3-methoxy-6-methoxymethoxy-phenylamine suppliers The collaborative research and exclusive license agreement inked in December didn’t have a price tag, but the two companies revealed the eye-popping figure Tuesday that includes an undisclosed upfront payment to PeptiDream and other cash drops subject to certain clinical milestones. [3-fluoro-2-(7-methanesulfinyl-1-methyl-1H-pyrimido[4,5-e][1,3,4]oxadiazin-3-yl)-phenyl]-dimethyl-amine vendor & factory.